Omeros Corporation

-0.08 (-3.67%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)131.73M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.35 Million
Adjusted EPS-$0.59
See more estimates
10-Day MA$2.37
50-Day MA$3.17
200-Day MA$4.23
See more pivots

Omeros Corporation Stock, NASDAQ:OMER

The Omeros Building, 201 Elliott Avenue West, Seattle, Washington 98119
United States of America
Phone: +1 206 676-5000
Number of Employees: 213


Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.